Palomo et al. demonstrated that TET2 and SRSF2 mutations are the most common founder mutations in CMML, while ASXL1/SETBP1 mutations co-occur frequently in aCML [7]. The gene discussed is ASXL1; the disease is chronic myelomonocytic leukemia.